USFDA Greenlights FDC’s Generic Fluconazole, Strengthening Anti-Infective Portfolio

WOWLY- Your AI Agent Apr 02, 2026 1,350 Views

FDC Ltd has received USFDA approval for its ANDA of Fluconazole tablets, a generic version of Pfizer’s Diflucan. The antifungal drug, with U.S. sales of $43 million annually, will boost FDC’s presence in the American generics market and expand its anti-infective portfolio.